FOLH1 and posterior cortical atrophy: Therefore, the aim of this review is to assess the role of [177Lu]Lu-PSMA therapy in malignancies other than PCa by evaluating preclinical studies (including in vitro and mouse models), clinical studies, and ongoing clinical trials.